Formulation and In Vivo Evaluation of Effervescent Inhalable Carrier Particles for Pulmonary Delivery of Nanoparticles
Authors:
- 1 January 2008
- journal article
- research article
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 34 (9) , 943-947
Abstract
The purpose of this study was to evaluate the safety of a new inhalable effervescent carrier preparation containing model nanoparticles. Spray-freeze drying was used to prepare inhalable powders containing butylcyanoacrylate nanoparticles. The particle size of the nanoparticles before incorporation into the effervescent carrier and after dissolving the carrier powder was measured using laser light scattering. The particle size distribution of the effervescent carrier aerosol particles was measured using a cascade impactor. The prepared powder was tested in vivo using five Balb/c nude mice. The animals were treated with 1 mg of inhalable powder every week for 4 weeks. The body weight and morbidity score of the mice were observed over an 8-week period. The effervescent activity of the inhalable nanoparticle powder was observed when the powder was exposed to humidity. The particle size of the nanoparticles did not change significantly after spray-freeze drying. The mass median aerodynamic diameter (MMAD) of the prepared powder was 4.80 +/- 2.12 microm, which is suitable for lung delivery. The animals that were treated with effervescent powder tolerated the administration without any changes in their morbidity scores. Our pilot study demonstrates that pulmonary nanoparticle delivery via effervescent carrier particles appears safe in the present animal model.Keywords
This publication has 12 references indexed in Scilit:
- Targeted delivery of nanoparticles for the treatment of lung diseasesAdvanced Drug Delivery Reviews, 2008
- Effervescent dry powder for respiratory drug deliveryEuropean Journal of Pharmaceutics and Biopharmaceutics, 2007
- Biophysical Investigation of Nanoparticle Interactions with Lung Surfactant Model SystemsJournal of Biomedical Nanotechnology, 2006
- Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particlesInternational Journal of Pharmaceutics, 2006
- Investigation of the proinflammatory potential of biodegradable nanoparticle drug delivery systems in the lungToxicology and Applied Pharmacology, 2006
- Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine ParticlesEnvironmental Health Perspectives, 2005
- Incorporation of biodegradable nanoparticles into human airway epithelium cells—in vitro study of the suitability as a vehicle for drug or gene delivery in pulmonary diseasesBiochemical and Biophysical Research Communications, 2004
- Pulmonary drug delivery. Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medicationsBritish Journal of Clinical Pharmacology, 2003
- Trojan particles: Large porous carriers of nanoparticles for drug deliveryProceedings of the National Academy of Sciences, 2002
- Dry powder inhalers2001